Therefore, RP-Mdm2-p53 signaling may play a general role in responding to oncogenic stress and suppressing tumorigenesis like it does in Myc-induced B cell lymphoma. The gene discussed is TP53; the disease is B-cell non-Hodgkin lymphoma.